John E. (Jack) Jr. Bailey
CIK 1806147 · President and CEO · last filed 2024-09-18
John E. (Jack) Jr. Bailey is a President and CEO who has filed 14 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for GTHX, was dated Sep 18, 2024. Across all open-market trades the lifetime net is −$820.4K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
14
-$820.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| G1 Therapeutics, Inc. (GTHX) Delisted | President and CEO | 0 | $7.15 | $0 | -$820.4K | 14 | 2024-09-18 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-18 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | −549,674 | $0 | EDGAR |
| 2024-07-08 | G1 Therapeutics, Inc. (GTHX) Delisted | Sell (S) | −7,662 | -$19.2K | EDGAR |
| 2024-07-03 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | +105,000 | $0 | EDGAR |
| 2024-05-15 | G1 Therapeutics, Inc. (GTHX) Delisted | Sell (S) | −37,258 | -$178.4K | EDGAR |
| 2024-01-08 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | +89,014 | -$36.4K | EDGAR |
| 2024-01-02 | G1 Therapeutics, Inc. (GTHX) Delisted | Sell (S) | −32,983 | -$108.0K | EDGAR |
| 2023-07-07 | G1 Therapeutics, Inc. (GTHX) Delisted | Sell (S) | −2,719 | -$6.7K | EDGAR |
| 2023-05-12 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | +160,000 | $0 | EDGAR |
| 2023-01-05 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | +43,074 | -$218.7K | EDGAR |
| 2022-01-05 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | +11,875 | -$355.3K | EDGAR |